Due to the inherent complexity of the many interconnected physiological, molecular and biochemical processes that exist in cancer cells, conventional experimental approaches alone are proving unable to unravel the convoluted layers of such processes as drug resistance, genetic and proteomic variations, and optimal therapeutic strategies.